Академический Документы
Профессиональный Документы
Культура Документы
Xu Zhi-Yue
Definition
Refers to a variety of pathogenic factors causing sharp
reduction in effective circulating blood volume, leading to
organ and tissue microcirculation, hypoperfusion, resulting in
tissue hypoxia, cell metabolism and organ dysfunction
syndrome
Deterioration in shock from inadequate tissue
perfusion is a development of multiple organ
dysfunction to the failure of the pathological process
Pathophysiology
Clinical Features
Diagnosis
Differential diagnosis
Etiology
Shock
Laboratory assistant
examination
Treatment
Cardiac output
CO = Stroke volumeHeart rate
Preload
Afterload
Myocardial contractility
Question
Preload can be made infinitely increase?
Afterload increases will not reduce
stroke volume?
where is Myocardial contractility
confined ?
The faster heart rate, cardiac output,
the larger it?
Critical shock
Acute lack
of effective circulating blood volume
Blood volume
Cardiac pump
dysfunction
Vascular
volume
shock
Etiology
hypovolemic shock
hypovolemic shock
cardiogenic shock
septic shock
allergic shock
neurogenic shock
Etiology
Shoc
k
Maldistributive
shock
cardiogenic shock
Cardiac obstructive
shock
Hemodynamic classification
Pathophysiology
contraction
Release
congestion
Catecholami
Microthrom
bi and DIC
ne
Aldosterone
Vasoactive
peptide
Microcir
culation
Metabolic
changes in body
fluids
Inflammator
y mediators
Endothelial
cell injury
Reperfusion
injury
Release of
inflammatory
mediators
Pathophysiological changes
MODS
Myocardial
depression
Alveolar
collapse
cerebral
edema
oliguria
Secondary
damage to
vital organs
Pathophysiology Stage
Early shock(Phase )
Shock medium(Phase )
Late shock(Phase )
(Micro-circulatory failure period)
Pathophysiology
2. Reversible decompensated
Catecholamine response to the small blood
vessels decreased
there microcirculation congestion
Pale or schungite, cold limbs, oliguria
Temperature did not rise, pulse rate, disturbance
of consciousness, low heart sound blunt, blood
pressure, or could not be check out
Acidosis obvious
There may be organ dysfunction or failure
Laboratory tests
Blood
Blood
Urine,
Urine, stool
stool
RBC/Hb
Judge
haemorrhagic
shock
Renal
function
WBC count
gastrointesti
nal bleeding
septic shock
Coagulation
Coagulation
Blood
Blood
biochemistry
biochemistry
Determine the
coagulation
Organ
examinations
X ray
Hemodynamic
CO
ECG
PCWP
CVP
Microcirculation
inspection
General monitoring
Mental state
Skin temperature, color
Blood pressure
Pulse rate
Urine
Special monitoring
shock
shock
Central venous pressure
PCWP
5-10cmH2O
(6-15mmHg)
Special
monitoring
CI
Blood gas
analysis
Lac
DIC
Gastrointestinal
Mucosa ph
Diagnosis
1 The incentive of a shock
2 Disturbance of consciousness
Diagnostic
3 Puls 100 m
4 Crt 3s ,urine 0.5ml/(kgh)
criteria
5 BP 90mmHg
6 Vessel pressure 30mmHg
7 Systolic pressure decrease > 30
Differential diagnosis
Distinguish
various types
shock
Physical
hypotension
Orthostatic
hypotension
Treatment principles
Remove the causes, incentives
Shock
treatmeint
To restore an effective
circulating blood volume
Correct the microcirculation
Improve heart function
Return to normal metabolic
General treatment 1
1
Sedation
head-down
oxygen
fasting
to reduce
the move
ECG
legs levated
BP
20 -30
heart failure
or pulmonary
edema were
semi-supine
Keep warm
Breath
SPo2
General treatment 2
5
Indwelling
catheter
to monitor
urine output
To add
volume
Improve
hypoxemia
Correct
acidosis
Vasoactive drugs
Low-dose 10g/(kgmin)
Dopamine
Dobutamine
Isoproterenol
High-dose 15g/(kgmin)
Vasoactive drugs
Norepin
ephrine
Adrenaline
Other drugs
Other drugs
Glucocorticoid
septic shock
Naloxone
allergic shock
Hydrocortisone
1.6mg 500ml,ivgtt
300-500mg/d 3
5d
1
Correcting water,
electrolyte and acidbase balance
disorders
to maintain effective
Additional capacity
should be only used
potent diuretics
cerebral edema:
dehydrating agent can
be used
renal perfusion
CRRT
Mechanical ventilation
Acute
respiratory
failure
Excited breathing
Reduce
intracranial
pressure
Cerebral
metabolic
activator
Treatment of
cerebral edema
Diazepam,
phenobarbital
support
treatment
Heparin
Added
coagulation
factor
Anti-platelet
aggregation
DIC
.Improve
Management of
microcirculation
Thrombolytic
therapy
complications
Gram-positive
bacterial
infections
Gram-negative
bacilli infection
Common
causes
Other pathogenic
microorganisms
Fungi
kidney:
skin changes:
CRT Extend
Hypoxic lactic acidosis 3mmol/l
Fluid resuscitation
Treatment of early target
1.Fluid infusion
2. Vasoactive drugs
Dopamine
MAP65mmHg
Norepinephrine,
urine0.5ml/kgh
Dobutamine
CVP or SvO270%
Fluid resuscitation
Treatment of early target
4. Added platelet